Wednesday, June 14, 2017 -- Researchers at North Carolina State University and the University of North Carolina at Chapel Hill have developed a new surgical tool that uses low-frequency intravascular ultrasound to break down blood clots that cause deep vein thrombosis. The tool is the first ultrasound “drill” that can be aimed straight ahead, allowing doctors to better target clots […] The post Deep vein thrombosis: North Carolina researchers develop first ultrasound ‘drill’ to target clots appeared first on Outbreak News Today.
Monday, May 22, 2017 -- LONDON (Reuters) - British pharmaceutical firm BTG said on Monday its EKOS combination therapy device for pulmonary embolism (PE) was effective using smaller drug dosages and shorter treatment periods than the current standard.
Friday, September 22, 2017 -- California-based ManaMed has launched the US Food and Drug Administration (FDA) approved deep vein thrombosis (DVT) prevention device – PlasmaFlow – in the US.
Monday, November 13, 2017 -- BACKGROUND Patients with suspected deep vein thrombosis (DVT) of the lower limb represent a diagnostic dilemma for general practitioners. Compression ultrasonography (US) is universally recognized as the best test of choice. We assessed the diagnostic accuracy of compression US performed by general practitioners given short training in the management of symptomatic proximal DVT. METHODS From May 2014 to May 2016, we evaluated in a multicenter, prospective cohort study all consecutive outpatients with suspected DVT; bilateral proximal lower limb compression US was performed by general practitioners and by physicians expert in vascular US, each group blinded to the other’s findings. In all examinations with a negative or nondiagnostic result, compression US was repeated by the same operator after 5 to
Thursday, May 18, 2017 -- Central venous access device (CVAD)-related thrombosis (CRT) is a common complication among patients requiring central venous access as part of their medical care. Complications of CRT include pulmonary embolism, recurrent deep venous thrombosis, loss of central venous access, and postthrombotic syndrome. Patient-, device-, and treatment-related factors can influence the risk of CRT. Despite numerous randomized controlled trials, the clinical benefit of pharmacologic thromboprophylaxis for the prevention of CRT remains to be established. Therefore, minimizing patient exposure to known risk factors is the best available approach to prevent CRT. Venous duplex is recommended for the diagnosis of CRT. Anticoagulation for at least 3 months or the duration of the indwelling CVAD is recommended for treatment of CRT. Thrombolysis should be
Wednesday, May 17, 2017 -- A 53-year-old woman presents to the emergency room for right upper extremity deep vein thrombosis after rib resection and subclavian vein stent placement.
Thursday, May 18, 2017 -- Ventilation and perfusion scans to diagnose pulmonary embolism remain largely accurate.
Thursday, May 25, 2017 -- Pulmonary embolism was associated with lupus, according to results of a recently published retrospective study. Srinadh Annangi, MBBS, from the Morehouse School of Medicine in Atlanta, and colleagues performed a retrospective analysis of the National Hospital Discharge Survey data between 2001 and 2010 of patients aged 15 years and older.
Tuesday, June 13, 2017 -- The clinical impact of positive airway pressure in patients with pulmonary embolism is not well known.
Tuesday, January 16, 2018 -- Patients diagnosed with an intermediate-risk pulmonary embolism may be able to start oral anticoagulation therapy after completing 72 hours of heparin therapy during hospitalization.
Wednesday, December 13, 2017 -- Several clinical predictors of pediatric pulmonary embolism have been identified.
Friday, September 29, 2017 -- Patients with saddle and nonsaddle pulmonary embolism have similar short-term outcomes, despite more serious symptoms being present in saddle pulmonary embolism.
Friday, May 19, 2017 -- A case study of a patient presented to the emergency room for right upper extremity deep vein thrombosis after rib resection and subclavian vein stent placement 15 years ago.
Tuesday, May 23, 2017 -- In our study pulmonary embolism was safely excluded by the YEARS diagnostic algorithm in patients with suspected pulmonary embolism. The main advantage of the YEARS algorithm in our patients is the absolute 14% decrease of CTPA examinations in all ages and across several relevant subgroups.
Tuesday, November 14, 2017 -- In European patients with low implicit clinical probability, PERC can exclude pulmonary embolism with a low percentage of false-negative results. The results of our prospective, observational study allow and justify an implementation study of the PERC rule in Europe.
Tuesday, September 12, 2017 -- LAS VEGAS — Use of a bioconvertible inferior vena cava filter successfully prevented new-onset pulmonary embolism in high-risk patients and was bioresorbed within 1 year in most cases, according to new data from the SENTRY study.IVC filters, when used properly, protect patients at risk from transient PE; however, some conventional filters are associated with high rates of complications due to device design or being left in too long. The FDA issued a warning to health care professionals to remove conventional filters when risk has passed, which is typically after 30 days, Michael D. Dake, MD, the Thelma and Henry Doelger professor of cardiovascular surgery and medical director of the catheterization and angiography laboratories at Stanford Health Care, said during
Thursday, December 07, 2017 -- Not all patients with blood clots in their legs – a condition known as deep vein thrombosis – need to receive powerful but risky clot-busting drugs, according to results of a large-scale, multicenter clinical trial.